The $25 million funding round stands out as one of the largest venture capital raises in the Baltimore region this year.

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today provided an update following the unblinding of clinical ...

A research team led by Erwin F. Wagner from the Medical University of Vienna has discovered a previously unknown molecular ...

The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), ...

Your skin is in a constant state of reinvention. Every month, your body sheds and regenerates its entire outer layer—a ...

The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...

In this video, Gailen D. Marshall Jr., MD, PhD, chair of allergy and immunology at University of Mississippi Medical Center, ...

Ankle swelling, often overlooked, can signal serious underlying health issues like heart, kidney, or liver problems, or ...

Adult-onset Still's disease (AOSD) is a rare inflammatory disorder. Thanks to a new initiative, AOSD is now considered to be ...

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of The University of Texas Medical Branch (UTMB) in ...

The future of dermatology is no longer just skin deep. This year’s American Academy of Dermatology (AAD) annual meeting was held March 7-11, 2025, in Orlando, FL, and it showcased the specialty’s ...

PsO is a systemic inflammatory disease that presents not only as scaly skin lesions, erythema, and itching but also affects ...